S-Ethylisothiouronium diethylphosphate
Chemical compound
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
S-Ethylisothiouronium diethylphosphate is a chemical compound that has been studied for its potential pharmacological properties. It is known for its role as a vasodilator, which means it can help to widen blood vessels and improve blood flow.
Chemical Structure
S-Ethylisothiouronium diethylphosphate is an organophosphorus compound. The structure consists of an isothiouronium group attached to a diethylphosphate moiety. The presence of the ethyl group in the isothiouronium part of the molecule is a distinguishing feature.
Pharmacological Properties
The compound is primarily recognized for its vasodilatory effects. As a vasodilator, S-Ethylisothiouronium diethylphosphate can be used to lower blood pressure by relaxing the smooth muscles in the blood vessel walls, thereby increasing the diameter of the vessels and allowing blood to flow more easily.
Mechanism of Action
The mechanism by which S-Ethylisothiouronium diethylphosphate exerts its effects involves the modulation of nitric oxide pathways. Nitric oxide is a key signaling molecule in the cardiovascular system, and its release leads to the relaxation of vascular smooth muscle cells. This compound may enhance the availability of nitric oxide or mimic its action, resulting in vasodilation.
Potential Applications
Due to its vasodilatory properties, S-Ethylisothiouronium diethylphosphate has potential applications in the treatment of conditions such as hypertension and angina pectoris. It may also be explored for use in other cardiovascular disorders where improved blood flow is beneficial.
Safety and Toxicity
As with many pharmacologically active compounds, the safety and toxicity of S-Ethylisothiouronium diethylphosphate must be carefully evaluated. Studies would typically assess its effects in various dosages to determine the therapeutic window and identify any adverse effects.
Related Compounds
S-Ethylisothiouronium diethylphosphate is related to other isothiouronium compounds, which may share similar pharmacological properties. These compounds are often studied for their potential therapeutic benefits in cardiovascular medicine.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
